Table 2. Overall prevalence [%] of different trypanosome species in different treatment regimens over an 18 months follow-up period.

Regimen	Month	n	T.vivax	T.b.brucei	T.c.savannah	Any Tryps	Number (n*)	Any Tryps*
1	0	408	0.2	0.0	0.0	0.2	na	na
2		317	0.6	0.0	0.0	0.6	na	na
3		467	1.5	0.2	0.0	1.7	na	na
4		433	0.9	0.0	0.0	0.9	na	na
5		356	3.1	0.0	0.0	3.1	na	na
1	3	273	4.0	0.4	1.1	5.1	268	4.9
2		294	1.0	0.0	0.3	1.4	294	1.4
3		415	3.6	0.0	0.2	3.9	414	3.9
4		355	2.8	0.0	0.3	3.1	338	3
5		355	5.9	0.0	0.3	6.2	353	5.9
1	6	359	8.9	1.4	2.5	12.8	316	13.3
2		308	1.0	0.3	0.0	1.3	264	1.1
3		375	1.9	0.0	0.0	1.9	326	2.1
4		361	5.0	0.8	1.1	6.6	309	5.5
5		316	10.1	0.6	0.3	10.4	263	11
1	9	307	9.1	0.3	1.6	10.7	257	11.7
2		299	2.7	0.3[1]	0.7	3.7	231	3.9
3		383	3.9	0.3	0.0	4.2	259	4.2
4		320	6.9	0.3	0.6	7.8	226	7.5
5		356	10.1	0.6	0.0	10.1	236	11
1	12	404	8.9	1.0	1.2	11.1	331	12.4
2		285	1.8	0.4	0.0	2.1	186	3.2
3		426	4.5	0.0	0.0	4.5	297	4.4
4		353	4.5	0.0	0.6	5.1	230	4.3
5		339	18.0	2.1	1.2	19.2	248	21
1	15	169	4.1	1.2	2.4	7.7	150	8.7
2		234	1.7	0.0	0.0	1.7	124	0.8
3		270	5.9	0.0	0.0	5.9	148	5.4
4		264	6.1	0.0	1.1	7.2	136	8.1
5		197	24.9	3.0	2.0	26.9	134	26.1
1	18	198	4.5	0.5	3.0	8.1	173	7.5
2		210	2.4	0.0	0.0	2.4	90	3.3
3		262	3.8	0.8	0.0	4.2	117	6.8
4		226	4.4	0.4	1.3	5.8	128	6.2
5		193	9.3	0.0	2.1	10.9	137	10.2

Any Tryps = Infected with any trypanosome species namely; T.vivax. T.b.brucei, T.b.rhodesiense, T.congolense (savannah); na; not applicable.

^[1]; one sample positive for SRA gene (T.b. rhodesiense).

* Only animals which received the initial DA are included.